Anesthetic gas may tame stubborn seizures when other drugs fail
NCT ID NCT05830864
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study reviewed medical records of 66 adults in intensive care who received the anesthetic gas isoflurane for severe seizures that didn't respond to standard treatments. Researchers wanted to see how often isoflurane stopped the seizures or led to full awakening. The goal is to find a backup option for these life-threatening situations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Isoflurane (an inhaled anesthetic)
What this could lead to
If results are positive, isoflurane could become a reliable option to stop prolonged seizures when other treatments fail.
What could go wrong
This is a small, retrospective review (66 patients), not a controlled trial, so results may not prove cause and effect. Isoflurane is an anesthetic with risks like low blood pressure and breathing problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY STATUS EPILEPTICUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Toulon - Sainte Musse
Toulon, 83000, France
-
CHU Brest
Brest, 29200, France
-
Ch Bethune Beuvry
Beuvry, 62660, France
-
GH Sud Ile de France, Hôpital de Melun-Sénart
Melun, 77000, France